Coming soon - Get a detailed view of why an account is flagged as spam!

view details

Fearless-Platform-41

User has not set a description

TOTAL KARMA: 2,359
LINK KARMA: 158
COMMENT KARMA: 2,201

Notes

Add Note

Account Strength

70/100

Email verified!

Created
3 years ago

Reddit profile u/Fearless-Platform-41

Profile updated: 1 day ago
Posts updated: 5 days ago

Media Library

see 1 more

Post Locations

New York City Vouched author Article Paper Maryland VOUCH VOUCH LIST Authors Costa Rica

User Flair

Vouch List

Their Subreddits

Monitored subreddits are highlighted

	Posts	Karma	KPP
r/nycgaybros	22	99	5
r/FoodNYC	1	80	80
r/biltrewards	2	53	27
r/avesNYC	10	20	2
r/avesNYC_tix	18	18	1
r/FinancialCareers	1	18	18
r/Scholar	11	11	1
r/RunNYC	4	10	3
r/longislandcity	1	2	2
r/ukrave	1	2	2
r/gaybrooklyn	1	2	2
r/shrooms	1	1	1
r/Techno	1	1	1
r/mensfashion	1	0	0
r/AskNYC	1	0	0
r/biotech	1	0	0
r/surfing	1	0	0

Post History

Filtering Fearless-Platform-41's posts by location: author clear filter or view all posts in author

Sort by:

Current filters

Location: author

Clear filters

to r/Scholar by Fearless-Platform-41

3 months ago

View Post: [Article] Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial [Author]: Rituparna Das, MD; Daniel Blázquez-Gamero, PhD;
David I Bernstein, MD

1

[Article] Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial [Author]: Rituparna Das, MD; Daniel Blázquez-Gamero, PhD; David I Bernstein, MD

Requesting

in author

Posted by Fearless-Platform-41

to r/Scholar

3 months ago in author